Tuscarawas County Health Department issued the following announcement on January 26.
The Food and Drug Administration is limiting the use of some monoclonal antibody treatments because they are ineffective against the omicron COVID variant, the agency announced Monday.
The therapies, made by Regeneron and Eli Lilly, should only be used when the “patient is likely to have been infected with or exposed to a variant that is susceptible to these treatments.”
Original source can be found here.
Alerts Sign-up